Search
Takeda Pharmaceutical Co Ltd
TAKAdd to Watchlist
15.630USD
+0.200+1.30%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
48.68BMarket Cap
40.75P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2026Q3
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Gastrointestinal diseases
385.81B
32.37%
Plasma derivatives
273.07B
22.91%
Rare diseases
193.98B
16.28%
Oncology
148.77B
12.48%
Neuroscience
108.35B
9.09%
Other
81.74B
6.86%
By RegionUSD
Name
Revenue
Proportion
United States
582.23B
48.86%
Europe And Canada (Country)
297.40B
24.96%
Japan
120.44B
10.11%
Latin America
72.88B
6.12%
China (Country)
48.45B
4.07%
Other
70.32B
5.90%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Gastrointestinal diseases
385.81B
32.37%
Plasma derivatives
273.07B
22.91%
Rare diseases
193.98B
16.28%
Oncology
148.77B
12.48%
Neuroscience
108.35B
9.09%
Other
81.74B
6.86%
